Arbutus Biopharma Corporation ABUS Operating margin

Operating margin at other companies

Arrowhead ResearchARWR

-35.7%+63.6pp

Gilead SciencesGILD

-8.2%-36.1pp

ALN

Alnylam PharmaceuticalsALNY

20.8%+16.5pp

AnaptysBio, Inc.ANAB

17.6%+9.6pp

Avalo TherapeuticsAVTX

-15,536.1%-17,275pp

Assembly BiosciencesASMB

-116.8%-26.1pp

FAQ

What is Arbutus Biopharma Corporation's operating margin?

Arbutus Biopharma Corporation (ABUS) reported operating margin of 81.7% in Q1 2026.

How has Arbutus Biopharma Corporation's operating margin changed year-over-year?

Arbutus Biopharma Corporation's operating margin increased by 106.3% year-over-year, from -1,290.9% to 81.7%.

What is the long-term trend for Arbutus Biopharma Corporation's operating margin?

Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's operating margin has grown at a -20.2% compound annual growth rate (CAGR), from -836.1% to -271%.

What does operating margin mean?

Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.